IRIS
TARZIA, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.177
EU - Europa 26.646
AS - Asia 10.879
SA - Sud America 699
AF - Africa 143
Continente sconosciuto - Info sul continente non disponibili 84
OC - Oceania 38
AN - Antartide 1
Totale 68.667
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.887
NL - Olanda 9.519
GB - Regno Unito 6.214
CN - Cina 5.715
SG - Singapore 2.826
UA - Ucraina 2.771
IT - Italia 1.810
SE - Svezia 1.653
TR - Turchia 1.133
DE - Germania 1.062
RU - Federazione Russa 944
FI - Finlandia 942
IE - Irlanda 597
FR - Francia 588
BR - Brasile 526
VN - Vietnam 406
CA - Canada 211
IN - India 194
JP - Giappone 133
BE - Belgio 114
PL - Polonia 105
EU - Europa 80
BD - Bangladesh 76
HK - Hong Kong 76
AR - Argentina 64
AT - Austria 61
ES - Italia 61
KR - Corea 56
IQ - Iraq 48
MX - Messico 45
RO - Romania 45
KE - Kenya 37
ZA - Sudafrica 36
AU - Australia 28
ID - Indonesia 26
PK - Pakistan 26
CH - Svizzera 25
CO - Colombia 22
CL - Cile 21
SA - Arabia Saudita 21
LT - Lituania 20
IR - Iran 18
EC - Ecuador 16
TG - Togo 16
MA - Marocco 14
VE - Venezuela 14
AL - Albania 13
PH - Filippine 13
PE - Perù 12
PY - Paraguay 11
JO - Giordania 10
NP - Nepal 10
AE - Emirati Arabi Uniti 9
EE - Estonia 9
GR - Grecia 9
HU - Ungheria 9
JM - Giamaica 9
NZ - Nuova Zelanda 9
UZ - Uzbekistan 9
AZ - Azerbaigian 8
DK - Danimarca 8
IL - Israele 8
CR - Costa Rica 7
DZ - Algeria 7
BG - Bulgaria 6
EG - Egitto 6
ET - Etiopia 6
HN - Honduras 6
KG - Kirghizistan 6
KZ - Kazakistan 6
LA - Repubblica Popolare Democratica del Laos 6
PT - Portogallo 6
AM - Armenia 5
BO - Bolivia 5
HR - Croazia 5
LU - Lussemburgo 5
LV - Lettonia 5
MD - Moldavia 5
MY - Malesia 5
OM - Oman 5
RS - Serbia 5
SM - San Marino 5
TN - Tunisia 5
TW - Taiwan 5
UY - Uruguay 5
CZ - Repubblica Ceca 4
LB - Libano 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
GE - Georgia 3
IS - Islanda 3
KW - Kuwait 3
NO - Norvegia 3
PA - Panama 3
AO - Angola 2
BB - Barbados 2
Totale 68.632
Salva come PNG Salva come JPEG
Città #
Amsterdam 9.481
Southend 5.676
Dallas 4.190
Woodbridge 3.099
Ann Arbor 2.232
Jacksonville 2.212
Houston 2.132
Ashburn 1.964
Chandler 1.869
Fairfield 1.852
San Jose 1.485
Singapore 1.451
Nanjing 1.223
Cambridge 895
Izmir 876
Wilmington 827
Beijing 735
Seattle 718
Boardman 542
Dublin 538
Nanchang 465
Helsinki 381
San Mateo 345
Princeton 317
Council Bluffs 310
New York 308
Lauterbourg 282
Düsseldorf 255
Hebei 249
Shenyang 242
Los Angeles 229
Tianjin 220
Changsha 200
Jiaxing 186
Kunming 162
Moscow 158
Istanbul 147
Munich 136
Des Moines 133
Velikiy Novgorod 125
Ho Chi Minh City 119
Santa Clara 116
Brussels 112
Shanghai 109
Toronto 94
Mülheim 93
Hanoi 92
Buffalo 86
San Diego 86
San Francisco 83
Urbino 83
Bremen 81
Jinan 79
Hangzhou 78
Milan 77
Guangzhou 73
Orem 71
Frankfurt am Main 68
London 68
Orciano Di Pesaro 61
Hong Kong 60
Lanzhou 59
Zhengzhou 58
Changchun 57
Venice 57
Dong Ket 54
Ningbo 53
Nuremberg 52
Stockholm 52
Warsaw 52
São Paulo 50
Tokyo 50
Menlo Park 48
Montreal 47
Chicago 46
Seongnam 45
Rome 44
Vienna 42
Dearborn 41
Kraków 40
Brooklyn 39
Turku 38
Norwalk 37
Haikou 36
Denver 35
Chennai 34
Shenzhen 34
Phoenix 30
Secaucus 28
Johannesburg 27
Taizhou 27
Manchester 26
Wuppertal 26
Auburn Hills 25
Nairobi 24
Rio de Janeiro 24
Augusta 23
The Dalles 23
Fuzhou 22
Mumbai 22
Totale 52.163
Salva come PNG Salva come JPEG
Nome #
1-(2-Alkylamidoethyl)-6-methoxyindole Derivatives: A New Class of Potent Indole Melatonin Analogues. 3.190
1-Aminocyclopropane-1-carboxylic acid derivatives as ligands at the glicine-site of the NMDA receptor. 3.185
1,7-DIHYDROPYRROLO[3,4-e][1,4]DIAZEPIN-2(3H)-ONE DERIVATIVES, AND THEIR USE AS ANTICONVULSANT AND ANTIANXIETY AGENTS 3.149
1,5-BENZODIAZEPINE-2,4-DIONE GASTRIN AND CHOLECYSTOKININ-B-RECEPTOR ANTAGONISTS 3.147
SULLA MICELIANAMMIDE 2.110
Inibitori dell’enzima NAAA (N-Acylethanolamine-Hydrolizing Acid Amidase) come nuovi agenti antinfiammatori 879
1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID DERIVATIVES AS LIGANDS AT THE GLYCINE-BINDING SITE OF THE N-METHYL-D-ASPARTATE RECEPTOR 433
Scoperta del primo inibitore dell’enzima idrolasi delle ammidi degli acidi grassi (FAAH) ad azione periferica 352
Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties 311
ORGANIC REACTIONS OF FLUOROXY COMPOUNDS: ADDITION REACTIONS OF UNACTIVATED AND DEACTIVATED UNSATURATED LINKAGES OF STEROIDS 291
Divergent synthesis of novel 9-deazaxanthine derivatives via late-stage cross-coupling reactions 290
Antidepressant-like Activity of the Fatty Acid Amide Hydrolase Inhibitor URB597 in a Rat Model of Chronic Mild Stress 288
Sintesi e studi di relazione struttura-attività/stabilità di carbammati inibitori dell’enzima FAAH 286
A Second Generation of Carbamate-Based Fatty Acid Amide Hydrolase Inhibitors with Improved Activity in vivo 284
3-(2-Carbamoylvinyl)-4,5-dimethylpyrrole-2-carboxylic acids as ligands at the NMDA glycine-binding site: a study on the 2-carbamoylvinyl chain modification 283
(E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists. 281
Tricyclic Alkylamides as Melatonin Receptor Ligands with Antagonist or Inverse Agonist Activity 277
Potent, Metabolically Stable 2-Alkyl-8-(2H-1,2,3-triazol-2-yl)-9H-adenines as Adenosine A2A Receptor Ligands 277
2-n-Butyl- 9-methyl-8-(1,2,3)triazol-2-yl-9H-purin-6-ylamine and Analogues as A2A Adenosine Receptor Antagonists. Design, Synthesis, and Pharmacological Characterization 276
A new melatonin receptor ligand with mt1-agonist and MT2-antagonist properties 274
Synthesis and Biological Activity of new melatonin dimeric derivatives. 273
4,5-Dihydroisoxazole and 4,5-dihydro-1,2,4-oxadiazole derivatives from cycloaddition reactions of nitrile oxides to alkyl N-(diphenylmethylene)-α ,β -dehydroamino acids 273
ENOLATES OF 17,20:20,21-BISMETHYLENEDIOXYPREDNISONE 271
An improved route to cycloalka[b]pyrrole 2-carboxylates 269
Structure–Property Relationships of a Class of Carbamate-Based Fatty Acid Amide Hydrolase (FAAH) Inhibitors: Chemical and Biological Stability 269
Alkyl 2 (Diphenyl-methyleneamino) acrylates in the Synthesis of α-Amino Acids 268
Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: Steric effects of N-alkyl chain on rat plasma and liver stability 267
Synthesis of benzo[1,2-d;3,4-d’]diimidazole and 1H-pyrazolo[4,3-b]pyridine as putative A2A receptor antagonists 266
Identification of a Bioactive Impurity in a Commercial Sample of 6-Methyl-2-p-tolylaminobenzo[d][1,3]oxazin-4-one (URB754) 257
10-(1-HYDROXYMETHYL)-11-OXO-1-AZATRICYCLOUNDEC-2-ENE-2-CARBOXYLIC ACID ESTERS USEFUL AS ANTIBACTERIAL AND PROCESS FOR THEIR PREPARATION 256
Synthesis and Biological Evaluation of Metabolites of 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535), A Potent Antagonist of the A2AAdenosine Receptor for the Treatment of Parkinson’s Disease 256
5-(2-Ethyl-phenyl)-3-(3-methoxy-phenyl)-1H-[1,2,4]triazole (DL-111-IT ) and related compounds induce morphological apoptotic patterns in cultures of human tumor cell lines 254
Reassessing the melatonin pharmacophore: enantiomeric resolution, pharmacological activity, structure analysis, and molecular modeling of a constrained chiral melatonin analogue. 253
"Hot spots" in Medicinal Chemistry 247
2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists 247
2,4,5-TRISUBSTITUTED OXAZOLES 246
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis 243
Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation 243
Application of a non-electrophysiological method to study binding affinity and efficacy of glicine analogs to the glicine site of the NMDA receptor-ion channel complex. 241
Anandamide suppressess pain initiation through a peripheral endocannabinoid mechanism 239
N (Diphenylmethylene)-α,β−didehydroamino Acid Esters. Thermal and Lewis Acid Induced Dimerizations 237
POSITIVE ION-MASS SPECTRA AND COLLISION-INDUCED DISSOCIATION OF SOME 2,3-DIDEHYDRO AMINO ACIDS 236
Cyclohexylcarbamic Acid 3’-or 4’-Substituted Biphenyl-3-yl Esters as Fatty Acid Amide Hydrolase Inhibitors: Synthesis Quantitative Structure–Activity Relationships, and Molecular Modeling Studies 235
Modulation of Anxiety Through Blockade of Anandamide Hydrolysis 233
2,3-Dehydroamino acid derivatives as intermediates in the synthesis of heterocyclic compounds. 233
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 233
N-(Substituted-anilinoethyl)acylamides: Design, Synthesis and Pharmacological Characterization of a New Class of Melatonin Receptor Ligands 230
5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht7 serotonin receptors, preparation, and therapeutic use.. 226
Bivalent Ligand Approach on N-[2-[(3-methoxyphenyl)methylamino]ethyl]acetamide. Synthesis, Binding Affinity and Intrinsic Acivity for MT(1) and MT(2) melatonin Receptors. 225
TEICOPLANIN HYDRAZIDES AS ANTIBACTERIALS 224
2,4-Dicarboxy-pyrroles as Selective Non-Competitive mGluR1 Antagonists: an exploration of the role of the pyrrolic scaffold 223
An endocannabinoid mechanism for stress-induced analgesia 222
Design and synthesis of N-[3,3-diphenyl-propenyl]alkanamides as a novel class of potent MT2-selective Melatonin receptor ligands 221
(E)-3-[2-(Carbamoylvinyl)]pyrrol-2-carboxylic acid derivatives: A novel Class of glycine site Antagonists. 221
N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands. 220
O-Biphenyl-3-yl Carbamates as Peripheral FAAH Inhibitors: Synthesis and Structure–Activity (SAR) Relationship Studies 219
3,6-DISUBSTITUTED TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES 218
N-(DIPHENYLMETHYLENE)-ALPHA,BETA-DIDEHYDROAMINO ACID ESTERS. THERMAL AND LEWIS ACID INDUCED DIMERIZATIONS 217
Mechanisms of action and antiproliferative properties of URB631 in human breast cancer 217
Toward the Definition of Stereochemical Requirements for MT(2)-Selective Antagonists and Partial Agonists by Studying 4-Phenyl-2-propionamidotetralin Derivatives 217
Peripherally Restricted FAAH Inhibitors 216
2,3-Dihydro-6,7-dichloro-pyrido[2,3-b]pyrazine-8-oxide as Selective Glycine Antagonist with in vivo Activity. 215
Synthesis and Structure–Activity Relationships of a Series of Pyrrole Cannabinoid Receptor Agonists 215
Synthesis and Structure–Activity Relationship (SAR) of 2-Methyl-4-oxo-3-oxetanyl Carbamic Acid Esters, a Class of Potent N-Acylethanolamine Acid Amidase (NAAA) Inhibitors 215
Differentiation between isomeric 1-aminocyclopropane-1-carboxylic acid derivatives by means of chemical ionisation and mass selected collision induced dissociation 214
N-acetiltriptamine 2,5-sostituite: sintesi e valutazione dell’attività biologica per i recettori melatoninergici MT1 e MT2 214
Conformationally Restrained Melatonin Analogs: Synthesis, Binding Affinity for the Melatonin Receptor, Evaluation of the Biological Activity, and Molecular Modeling Study 214
N-Acyl-5- and -2,5-substituted tryptamines: synthesis, activity and affinity for human mt1 and MT2 melatonin receptors 213
X-RAY STRUCTURE DETERMINATION OF MEXIPROSTIL, A NEW GASTROPROTECTIVE 16-METHOXY-16METHYL-PGE1 ANALOGUE 212
Synthesis, Enantiomeric Resolution and Structure-Activity Relationship Study for a Series of 10,11-Dihydro-5H-dibenzo[a,d]cycloheptene MT2 Receptor Antagonists. 212
Synthesis and Quantitative Structure–Activity Relationship of Fatty Acid Amide Hydrolase Inhibitors: Modulation at the N-Portion of Biphenyl-3-yl Alkylcarbamates 211
Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand 210
Synthesis of (E)-8-(3-Chlorostyryl)caffeine Analogues Leading to 9-Deazaxanthine Derivatives as Dual A2AAntagonists/MAO-B Inhibitors 210
2-N-Acylaminoalkylindoles: Design and Quantitative Structure-Activity Relationship Studies Leading to MT2-Selective Antagonists. 209
The Fatty Acid Amide Hydrolase Inhibitor URB597 (Cyclohexylcarbamic Acid 3’-Carbamoylbiphenyl-3-yl Ester) Reduces Neuropathic Pain after Oral Administration in Mice 209
(2-AMINOETHYL)IMIDAZOLES.SYNTHESIS OF 1,4-DIMETHYL-5-PHENYL-2-[2-(4-PHENYLPIPERAZINYL)ETHYL]IMIDAZOLE 208
Plant-derived phenolic compounds prevent the DNA single-strand breakage and cytotoxicity induced by tert-butylhydroperoxide via an iron-chelating mechanism. 207
Sintesi e studi biologici preliminari su analoghi di URB937, il primo inibitore ad azione periferica dell'enzima FAAH 206
Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models 204
Structural determinants of peripheral O-arylcarbamate FAAH inhibitors render them dual substrates for Abcb1 and Abcg2 and restrict their access to the brain 203
MELATONIN RECEPTOR AGONISTS: SAR AND APPLICATIONS TO THE TREATMENT OF SLEEP-WAKE DISORDERS 202
2 - Arachidonoylglycerol and anandamide are endocannabinoid mediators of stress - induced analgesia 201
SYNTHESIS, BINDING AFFINITY FOR THE MELATONIN RECEPTOR, AND EVALUATION OF THE BIOLOGICAL ACTIVITY OF NEW INDOLE-BASED MELATONIN ANALOGUES. 200
GENERALISED ELECTROPHILIC FLUORINATION BY FLUOROXY COMPOUNDS 200
Alchilammidi tricicliche: legandi selettivi dei recettori melatoninergici MT1 e MT2 199
SUITABILITY OF FAST-ION BOMBARDMENT MASS SPECTROMETRY FOR THE INVESTIGATION OF 11,4-DIHYDROPYRIDINE DERIVATIVES 197
Design, Synthesis and Structure–Activity Relationships of Alkylcarbamic Acid Aryl Esters, a New Class of Fatty Acid Amide Hydrolase Inhibitors 196
UNIVERSITY EDUCATION OF MEDICINAL CHEMISTS: COMPARISON OF EIGHT COUNTRIES 194
2-(1,1'-BIPHEN-4-YL)-1,2,4-TRIAZOLE[5,1-a]ISOQUINOLINE (L-14105), A POTENTIAL ORALLY ACTIVE CONTRAGESTATIONAL AGENT FOR THE BITCH: STUDIES IN THE RAT, HAMSTER AND DOG 194
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus 194
N-(2-Oxo-3-oxetanyl)carbamic Acid Esters as N-Acylethanolamine Acid Amidase Inhibitors: Synthesis, Structure–Activity and Structure–Property Relationships 194
URB602 Inhibits Monoacylglycerol Lipase and Selectively Blocks 2-Arachidonoylglycerol Degradation in Intact Brain Slices 193
Pharmacological characterization of hydrolysis resistano analogs of oleoylethanolamide with potent anorexiant properties 193
Metastable ion studies in the characterization melatonin isomers 193
Modulation of anxiety through blockade of anandamide hydrolysis 193
SYNTHESIS AND BIOLOGICAL PROPERTIES OF N63-CARBOXAMIDES OF TEICOPLANIN ANTIBIOTICS. STRUCTURE-ACTIVITY RELATIONSHIPS. 192
Synthesis and Structure–Activity Relationships of N-(2-Oxo-3-oxetanyl)amides as N-Acylethanolamine-hydrolyzing Acid Amidase Inhibitors 191
ANGIOTENSIN CONVERTING ENZYME INHIBITORS AS ANTIHYPERTENSIVE AGENTS: 1-[´2-MERCAPTOCYCLOALKYL`CARBONYL]-L-PROLINES 190
DEAMINOTEICOPLANIN AND ITS DERIVATIVES. SYNTHESIS, ANTIBACTERIAL ACTIVITY, AND BINDING STRENGTH TO Ac-D-ALA-D-ALA 190
2-n-butyl-9-methyl-8-(1,2,3)triazol-2yl-9H-purin-6-yl-amine (ST 1535) and analogs as A2a Adenosine receptor antagonists. Design, synthesis and pharmacological characterization 190
Totale 37.621
Salva come PNG Salva come JPEG
Categoria #
all - tutte 199.673
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 199.673
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021320 0 0 0 0 0 0 0 0 0 0 0 320
2021/20223.235 188 375 398 514 74 84 111 202 219 136 41 893
2022/20235.271 613 291 153 643 460 1.157 15 428 868 137 354 152
2023/20241.271 165 132 78 157 81 294 65 80 19 88 22 90
2024/20254.519 285 248 1.123 275 98 424 452 305 369 254 376 310
2025/202622.957 769 2.014 3.712 1.659 789 808 1.428 354 10.008 673 608 135
Totale 68.951